Abstract:Key PointsThe molecular mechanism of activation for a representative effector caspase, caspase-7, is revealed by the conformational changes of the active site that take place after the activation cleavage. The essence of this mechanism is the provision of the L2′ loop, which is released by the activation cleavage and provides crucial support for the conformation of the active site.The molecular mechanism of inhibitor of apoptosis (IAP)-mediated inhibition of an effector caspase primarily involves the occupation of the caspase active site by an extended peptide fragment that immediately precedes the second baculoviral IAP repeat (BIR) domain, BIR2, of XIAP, c-IAP1 or c-IAP2.The BIR3 domain of XIAP inhibits caspase-9, an initiator caspase, by sequestering caspase-9 in a monomeric state, so that the L2′ loop cannot be provided by the adjacent monomer and the active site cannot be productively formed. This inhibition is dependent on, and initiated by, the binding between a conserved surface groove of the BIR3 domain of XIAP and the N-terminal tetrapeptide (Ala-Thr-Pro-Phe) of the small subunit of caspase-9.The viral protein p35 inhibits a caspase through the formation of a covalent thioester bond between the catalytic residue Cys360 of caspase-8 and Asp87 of p35, which follows caspase-mediated cleavage of the reactive-site loop of p35 after Asp87.The XIAP-mediated inhibition of caspase-9 can be countered effectively by SMAC/DIABLO, which uses its N-terminal tetrapeptide (Ala-Val-Pro-Ile) to compete with caspase-9 for binding to the same conserved surface groove of the BIR3 domain of XIAP. In Drosophila melanogaster, the caspase-9 orthologue Dronc is suppressed by Diap1 through an interaction that involves an internal peptide fragment of Dronc and the conserved surface groove of the BIR2 domain of Diap1. The pro-apoptotic proteins Reaper, Hid, Grim and Sickle use their N-terminal peptide fragments (which are similar to the SMAC/DIABLO tetrapeptide) to compete with Dronc for binding to the same conserved surface groove, thereby removing the Diap1-mediated negative regulation of Dronc.The exact mechanisms for the removal of effector-caspase inhibition remain to be defined. The prevailing model, which is supported by biochemical data, is that the binding of effector caspases by SMAC/DIABLO creates steric hindrance that dissociates the interaction between IAPs and the effector caspases.To gain a comprehensive picture of the molecular mechanisms of caspase regulation, future efforts should be directed at understanding the activation of initiator caspases and caspase pathways in Drosophila melanogaster and Caenorhabditis elegans.

Phosphorylation of I k Ba Inhibits Its Cleavage by Caspase CPP 32 in Vitro *

Phosphorylation Of I Kappa B-Alpha Inhibits Its Cleavage By Caspase Cpp32 In Vitro

Cleavage and Activation of p21-activated Protein Kinase γ-PAK by CPP32 (Caspase 3): EFFECTS OF AUTOPHOSPHORYLATION ON ACTIVITY

Direct cleavage by the calcium-activated protease calpain can lead to inactivation of caspases.

Cleavage of RIP3 inactivates its caspase-independent apoptosis pathway by removal of kinase domain.

Cleavage of RIPK1 by caspase-8 is crucial for limiting apoptosis and necroptosis

Regulation of Linear Ubiquitin Chain Assembly Complex by Caspase-Mediated Cleavage of Rnf31

Negative Regulation of Caspase 3-Cleaved PAK2 Activity by Protein Phosphatase 1.

Phosphorylation of caspases by a bacterial kinase inhibits host programmed cell death

Interferon-γ induces the cell surface exposure of phosphatidylserine by activating the protein MLKL in the absence of caspase-8 activity

RIPK3 cleavage is dispensable for necroptosis inhibition but restricts NLRP3 inflammasome activation

Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis

Mutations that prevent caspase cleavage of RIPK1 cause autoinflammatory disease.

Protein phosphatase 1 regulates phosphorylation of Gasdermin D and pyroptosis

Downregulation of ANP32B, a Novel Substrate of Caspase-3, Enhances Caspase-3 Activation and Apoptosis Induction in Myeloid Leukemic Cells

Molecular mechanisms of caspase regulation during apoptosis

Regulation of Innate Immune Responses by Receptor Interacting Protein Kinases (172.43)

Caspase-3-resistant uncleavable form of acidic leucine-rich nuclear phosphoprotein 32B potentiates leukemic cell apoptosis.

Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis

The 90-Kda Ribosomal S6 Kinase (pp90rsk) Phosphorylates the N-terminal Regulatory Domain of IκBα and Stimulates Its Degradation in Vitro

RIPK1 Dephosphorylation and Kinase Activation by PPP1R3G/PP1γ Promote Apoptosis and Necroptosis.